Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
58
SUPN Quote, Financials, Valuation and Earnings
Last price:
$33.59
Seasonality move
:
-1.83%
Day range:
$32.91 - $34.05
52-week range:
$27.05 - $40.28
Dividend yield:
0%
P/E ratio:
30.20x
P/S ratio:
2.81x
P/B ratio:
1.82x
Volume:
1.2M
Avg. volume:
704.9K
1-year change:
15.83%
Market cap:
$1.9B
Revenue:
$661.8M
EPS (TTM):
$1.11
Earnings Data
Next earnings date for SUPN
Aug 06
2025
Most recent earnings per share
-$0.21
Missed by $0.58
(May 6/2025)
Consensus Estimate
$0.37
(May 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SUPN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $161.4M | -- | -- | $0.52 | -- |
| 08/06/2025 | Q2 | $154.1M | -- | -- | $0.47 | -- |
| 05/06/2025 | Q1 | $147.9M | $149.8M | -$0.21 | $0.37 | -$0.58 |
| 02/25/2025 | Q4 | $155.3M | $174.2M | $0.27 | $0.52 | -$0.25 |
| 11/04/2024 | Q3 | $157.3M | $175.7M | $0.69 | $0.44 | $0.25 |
| 08/06/2024 | Q2 | $148.9M | $168.3M | $0.36 | $0.39 | -$0.03 |
| 05/08/2024 | Q1 | $145.8M | $143.6M | $0.00 | $0.38 | -$0.37 |
| 02/27/2024 | Q4 | $155M | $164.3M | $0.02 | $0.55 | -$0.54 |
| 11/08/2023 | Q3 | -- | -- | -$0.29 | $0.08 | -$0.37 |
| 08/08/2023 | Q2 | -- | -- | -$0.02 | $0.21 | -$0.23 |
| 05/09/2023 | Q1 | -- | -- | $0.29 | $0.31 | -$0.02 |
| 02/28/2023 | Q4 | -- | -- | $0.43 | $0.68 | -$0.25 |
| 11/08/2022 | Q3 | -- | -- | $0.03 | $0.36 | -$0.33 |
| 08/04/2022 | Q2 | -- | -- | $0.14 | $0.29 | -$0.15 |
| 05/09/2022 | Q1 | -- | -- | $0.43 | $0.45 | -$0.02 |
| 02/28/2022 | Q4 | -- | -- | $0.04 | $0.24 | -$0.20 |
| 11/03/2021 | Q3 | -- | -- | $0.40 | $0.23 | $0.17 |
| 08/04/2021 | Q2 | -- | -- | $0.43 | $0.20 | $0.23 |
| 05/05/2021 | Q1 | -- | -- | $0.11 | $0.24 | -$0.13 |
| 02/25/2021 | Q4 | -- | -- | $0.57 | $0.49 | $0.08 |
| 11/03/2020 | Q3 | -- | -- | $0.74 | $0.27 | $0.47 |
| 08/18/2020 | Q2 | -- | -- | $0.65 | $0.42 | $0.23 |
| 05/05/2020 | Q1 | -- | -- | $0.40 | $0.26 | $0.14 |
| 02/25/2020 | Q4 | -- | -- | $0.62 | $0.59 | $0.03 |
| 11/05/2019 | Q3 | -- | -- | $0.54 | $0.59 | -$0.05 |
| 08/06/2019 | Q2 | -- | -- | $0.61 | $0.60 | $0.01 |
| 05/07/2019 | Q1 | -- | -- | $0.34 | $0.47 | -$0.13 |
| 02/26/2019 | Q4 | -- | -- | $0.48 | $0.29 | $0.19 |
| 11/06/2018 | Q3 | -- | -- | $0.52 | $0.42 | $0.10 |
| 08/07/2018 | Q2 | -- | -- | $0.57 | $0.45 | $0.12 |
| 05/08/2018 | Q1 | -- | -- | $0.49 | $0.32 | $0.17 |
| 02/27/2018 | Q4 | -- | -- | $0.26 | $0.28 | -$0.02 |
| 11/06/2017 | Q3 | -- | -- | $0.30 | $0.28 | $0.02 |
| 08/03/2017 | Q2 | -- | -- | $0.33 | $0.24 | $0.09 |
| 05/10/2017 | Q1 | -- | -- | $0.19 | $0.25 | -$0.06 |
| 02/28/2017 | Q4 | -- | -- | $0.26 | $0.24 | $0.02 |
| 01/03/2017 | Q3 | -- | -- | $0.36 | $0.34 | $0.02 |
| 08/03/2016 | Q2 | -- | -- | $0.18 | $0.13 | $0.05 |
| 05/03/2016 | Q1 | -- | -- | $0.08 | $0.08 | -- |
| 03/02/2016 | Q4 | -- | -- | $0.14 | $0.06 | $0.08 |
| 11/04/2015 | Q3 | -- | -- | $0.08 | $0.02 | $0.06 |
Supernus Pharmaceuticals Earnings Questions
-
How Much did Supernus Pharmaceuticals Generate in Revenue Last Quarter?
Supernus Pharmaceuticals reported $149.8M worth of top line sales in its most recent quarter.
-
Did Supernus Pharmaceuticals Beat Earnings Last Quarter?
Supernus Pharmaceuticals announced earnings per share of -$0.21 which represents a miss of analyst forecast a $0.37 per share.
-
Is Supernus Pharmaceuticals Profitable?
Supernus Pharmaceuticals reported $134.1M that represents $2.40 per share over the last quarter.
-
What is the Analyst Consensus for Supernus Pharmaceuticals EPS Next Year?
Supernus Pharmaceuticals's earnings are forecast to grow from $1.32 per share to $2.87 per share next year representing an increase of 57.2%.
-
When is Supernus Pharmaceuticals's Earnings Date?
Supernus Pharmaceuticals's next earnings date is August 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
